Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the anticipated market size of the injectable cement industry over the next few years?
The injectable cement market size has grown strongly in recent years. It will grow from $1.45 $ billion in 2024 to $1.55 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing incidence of osteoporosis, increasing incidence of bone fractures, growing demand for joint replacement surgeries, regulatory approvals, and the and the market entry of new products.
The injectable cement market size is expected to see strong growth in the next few years. It will grow to $2 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to an aging population, increasing bone health concerns, the expansion of healthcare infrastructure, increasing adoption of outpatient care, and a and a rising incidence of sports-related injuries. Major trends in the forecast period include enhanced biocompatibility, antibiotic-loaded cement innovations, minimally invasive application techniques, patient-specific solutions, and smart cement with monitoring capabilities.
Download Your Free Sample PDF:
What emerging drivers are expected to shape the future of the injectable cement market?
The increasing number of sports-related injuries is expected to propel the growth of the injectable cement market going forward. Sports-related injuries are physical damages sustained during athletic activities, including strains, sprains, fractures, and concussions, often requiring medical attention and rehabilitation for recovery. The rise in sports-related injuries is likely attributed to increased participation in athletic activities, more intense training regimens, and advancements in sports equipment that push physical limits, leading to higher injury rates among athletes worldwide. Injectable cement is used to treat sports-related injuries to stabilize fractures, support bone healing, and enhance surgical outcomes by providing a reliable and minimally invasive solution for bone reinforcement. For instance, in 2023, according to the National Safety Council, a US-based nonprofit organization dedicated to health and safety, the number of sports and recreational injuries reported saw a 20% increase in 2021, followed by a 12% rise in 2022 and a 2% uptick in 2023. Therefore, increasing sports-related injuries will drive the growth of the injectable cement market.
What emerging segments are shaping the future landscape of the injectable cement industry?
The injectable cementmarket covered in this report is segmented –
1) By Type: High Viscosity Cement, Low Viscosity Cement, Medium Viscosity Cement
2) By Application: Periprosthetic Fractures, Pelvic Fractures, Other Applications
3) By End User: Hospital, Clinics, Other End Users
Subsegments:
1) By High Viscosity Cement: Calcium Phosphate Cements, PMMA (Polymethyl Methacrylate) Cements
2) By Low Viscosity Cement: Acrylic-Based Injectable Cements, Bioactive Glass Cements
3) By Medium Viscosity Cement: Hybrid Injectable Cements, Composite Injectable Cements
View The Full Market Report:
What evolving trends are creating new opportunities in the injectable cement market?
Major companies operating in the injectable cement market are focusing on technological advancements such as antibiotic-loaded bone cement to enhance infection control, improve patient outcomes, and support more effective and targeted treatment during orthopedic surgeries. Antibiotic-loaded bone cement is a type of bone cement that contains antibiotics mixed into the cement material to help prevent or treat infections at the surgical site, particularly in orthopedic procedures. For instance, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, launched COPAL G+C, its latest antibiotic-loaded bone cement. It is the first product from the company to be certified under the MDR. COPAL G+C combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly associated with prosthetic joint infections.
How are key players in the injectable cement market strengthening their market position?
Major companies operating in the injectable cement market are Johnson & Johnson, 3M Company, Medtronic Plc., Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew, Arthrex Inc., Cook Medical LLC, Enovis Corporation, Globus Medical Inc., Wright Medical Group N.V, Medacta International, Orthofix Medical Inc., Alphatec Spine Inc. (ATEC Spine), Exactech Inc., Spine Wave Inc., Tecres SpA, Somatex Medical Technologies, Heraeus Medical GmbH, DJO Global Inc., TEKNIMED, G-21, Kyeron Medical Innovations, Graftys SA
Which geographic areas are contributing significantly to the growth of the injectable cement sector?
North America was the largest region in the injectable cement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Injectable Cement Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Injectable Cement Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment